Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease

Clinical Nephrology

Volumn 71, Issue 1, 2009, Pages 9-20

  Masai, R ^a   Wakui, H ^a   Togashi, M ^a   Maki, N ^a   Ohtani, H ^b   Komatsuda, A ^a   Sawada, K ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Akita Kumiai General Hospital   (Japan)

Author keywords

Clinicopathological features; Heavy chain deposition disease; Light and heavy chain deposition disease; Light chain deposition disease; Prognosis

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CYTOTOXIC AGENT; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; PARAPROTEIN; STEROID; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GLOMERULOPATHY; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN DEPOSITION DISEASE; IMMUNOGLOBULIN LIGHT AND HEAVY CHAIN DEPOSITION DISEASE; IMMUNOGLOBULIN LIGHT CHAIN DEPOSITION DISEASE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FAILURE; LOW DRUG DOSE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PARAPROTEINEMIA; PROGNOSIS; PROTEIN LOCALIZATION; PROTEINURIA; SURVIVAL; COHORT ANALYSIS; KIDNEY DISEASE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY DISEASES; MALE; MIDDLE AGED; PARAPROTEINEMIAS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 63249128306     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71009     Document Type: Article

References (28)

1. Alchi B, Nishi S, Iguchi S, Shimotori M, Sakatsume M, Ueno M, Narita I, Saito K, Takahashi K, Gejyo F. Recurrent light and heavy chain deposition disease after renal transplantation. Nephrol Dial Transplant. 2005; 20: 1487-1491.
2. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition disease and their relation to light chain amyloidosis. Ann Intern Med. 1990; 112: 455-464.
3. Buxbaum JN. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease. Amyloid. 2001; 8: 84-93.
4. Chang IJ, Cheunsuchon B, Miller FJ, Fogo AB. A 66-year-old woman with progressive renal insufficiency, nephrotic syndrome, and monoclonal protein. Am J Kidney Dis. 2003; 41: 508-517.
5. Daliani D, Weber D, Alexanian R. Light-heavy chain deposition disease progressing to multiple myeloma. Am J Hematol. 1995; 50: 296-298.
6. Grogan TM, Van Camp B, Kyle RA, Müller-Hermelink HK, Harris NL. Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization classification of tumors: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon. IARC Press; 2001. p. 142-156.
7. Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997; 51: 270-276.
8. Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P D'Agati V.D. Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis. 1999; 33: 954-962.
9. Komatsuda A, Wakui H, Ohtani H, Kodama T, Miki K, Imai H, Miura AB. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy. Am J Kidney Dis. 2000; 35: E9.
10. Komatsuda A, Maki N, Wakui H, Ohtani H, Hatakeyama T, Yasuda T, Nakamoto Y, Imai H, Sawada K. Development of systemic λ-light chain amyloidosis in a patient with λ-heavy chain deposition disease during long-term follow-up. Nephrol Dial Transplant. 2005; 20: 434-437.
11. Komatsuda A, Masai P, Ohtani H, Togashi M, Maki N, Sawada K, Wakui H. Monoclonal immunoglobulin deposition disease associated with membranous features. Nephrol Dial Transplant. 2008; in press.
12. Lin J-J, Miller F, Waltzer W, Kaskel FJ. Arbeit L. Recurrence of immunoglobulin A-Κ crystalline deposition disease after kidney transplantation. Am J Kidney Dis. 1995; 25: 75-78.
13. Lin J. Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001; 12: 1482-1492.
14. Miletic VD, Frank MM. Complement-immunoglobulin interactions. Curr Opin Immunol. 1995, 7: 41-47.
15. Nakamoto Y, Kawamura K, Mamiya S, Yasuda T, Imai H, Miura AB, Hayashi M. Kappa light chain nodular glomerulosclerosis with conspicuous crescent formation and tubulointerstitial injury. Acta Pathol Jpn. 1992; 42: 439-447.
16. Nakatsuka A, Maeshima Y, Sarai A, Yanai H, Sugiyama H, Yamasaki Y, Makino H. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy.. Clin Nephrol. 2005; 64: 221-227.
17. Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D'Agati VD. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004; 65: 85-96.
18. Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB. Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis. 2003; 42: 87-95.
19. Pozzi C, D'Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S, Quattrocchio G, Rollino C, Segagni S, Locatelli F. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis. 2063; 42: 1154-1163.
20. Preud'homme JL, Morel-Maroger L, Brouet JC, Mihaesco E, Mery JP, Seligmann M. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol. 1980; 42: 545-553.
21. Preud'homme J-L, Aucouturier P, Touchard G, Striker L, Khamlichi AA, Rocca A, Denoroy L, Cogné M. Monoclonal immunoglobulin deposition disease (Randall Type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int. 1994; 46: 965-972.
22. Ronco P, Plaisier E, Mougenot B, Aucouturier P. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol. 2006; 1: 1342-1350.
23. Royer B, Arnulf B, Martinez F, Roy L, Flageul B, Etienne I, Ronco P, Brouet J-C, Fermand J-P. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int. 2004; 65: 642-648.
24. Sakakima M, Fujigaki Y, Tsuji T, Fukasawa H, Miyaji T, Naito K, Yamamoto T, Yonemura K, Ohnishi K, Hishida A. High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein. Intern Med. 2005; 44: 970-974.
25. Santostefano M, Zanchelli F, Zaccaria A, Poletti G, Fusaroli M. The ultrastructural basis of renal pathology in monoclonal gammopathies. J Nephrol. 2005; 18: 659-675.
26. Satirapoj B, Paueksakon P. A concurrence of light and heavy chain deposition disease and diabetic nephropathy. J Med Assoc Thai. 2007; 90: 2204-2208.
27. Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, Abbas A, Aucouturier P. Immunoglobulin γ3-heavy-chain deposition disease: report of a case and relationship with hypocomplememcmia. Am J Kidney Dis. 2004; 43: E2.
28. Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol. 1995; 44: 394-399.